SecurityVRTX / Vertex Pharmaceuticals Inc.
InstitutionOdey Asset Management Group Ltd
Shares11,430
Value $ 1,943,000

Odey Asset Management Group Ltd ownership in VRTX / Vertex Pharmaceuticals Inc.

August 20, 2018 - Odey Asset Management Group Ltd has filed a 13F-HR/A form disclosing ownership of 11,430 shares of Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) with total holdings valued at $1,943,000 USD as of June 30, 2018. Odey Asset Management Group Ltd had filed a previous 13F-HR on May 15, 2018 disclosing 11,430 shares of Vertex Pharmaceuticals Inc. at a value of $1,863,000 USD. This represents a change in shares of 0.00 percent and a change in value of 4.29 percent during the quarter.

Other investors with positions similar to Odey Asset Management Group Ltd include Silvercrest Asset Management Group Llc, IFM Investors Pty Ltd, United Capital Financial Advisers, Llc, Cigna Investments Inc /new, Kelly Lawrence W & Associates Inc/ca, and American Research & Management Co..

VERTEX PHARMACEUTICALS INC / MA has declared a standard industrial code (sic) of 2834 which is the "Pharmaceutical Preparations" industry. Odey Asset Management Group Ltd's top industries are "Mining And Quarrying Of Nonmetallic Minerals, Except Fuels" (sic 14), "Furniture And Fixtures" (sic 25), and "Primary Metal Industries" (sic 33).

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR/A-1 VERTEX PHARMACEUTICALS COM 92532F100 166.49 11,430 0.00 1,943 4.29 0 80 4.29
2018-06-30 13F-HR VERTEX PHARMACEUTICALS COM 92532F100 11,430 1,943
2018-03-31 13F-HR VERTEX PHARMACEUTICALS COM 92532F100 156.43 11,430 0.00 1,863 8.76 0 150 8.76
2017-12-31 13F-HR VERTEX PHARMACEUTICALS COM 92532F100 150.97 11,430 -6.80 1,713 -8.15 -126 -26 -1.40
2017-09-30 13F-HR VERTEX PHARMACEUTICALS COM 92532F100 140.45 12,264 0.00 1,865 18.04 0 285 18.04
2017-06-30 13F-HR VERTEX PHARMACEUTICALS COM 92532F100 12,264 1,580


CUSIP: 92532F100